Clinical Trials on Pancreas Adenocarcinoma in China

Total 1939 results

Dong Yang

Unknown

The Application of Fluorescence Laparoscopy in the Treatment of Adenocarcinoma of the Esophagogastric Junction

Adenocarcinoma of the Esophagogastric Junction | Fluorescence Laparoscopy

China
Wuhan Union Hospital, China

Recruiting

Neoadjuvant Sintilimab Plus Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction

Gastroesophageal Junction Cancer | PD-1 | Neoadjuvant Chemoradiotherapy

China
Renyi Qin

Completed

Minimally Invasive Versus Open Surgery for PHC

Perihilar Cholangiocarcinoma

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma

Perihilar Cholangiocarcinoma

China
Henan Cancer Hospital

Active, not recruiting

SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction Adenocarcinoma

Gastric Cancer

China
Henan Cancer Hospital

Active, not recruiting

Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma

Gastric Cancer

China
Zhujiang Hospital

Unknown

Impact of Three-dimensional Visualization on Operation Strategy and Complications for Hilar Cholangiocarcinoma

Hilar Cholangiocarcinoma

China
Fujian Medical University

Unknown

Comparison Between Robotic, Endoscopic and Traditional Open Surgery in Thyroidectomy

Endoscopy | Papillary Thyroid Carcinoma | Thyroidectomy | Robotics

China
Guangdong Provincial People's Hospital

Recruiting

Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors (FAPI)

Renal Cell Carcinoma | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Mucinous Adenocarcinoma | Signet Ring Cell Carcinoma

China
Shanghai Ninth People's Hospital Affiliated to...

Recruiting

Surufatinib in Recurrent/Metastatic Head and Neck Adenocarcinomas

Head and Neck Cancers - Salivary Gland

China
Shanghai Zhongshan Hospital

Recruiting

PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment

Cholangiocarcinoma, Intrahepatic | PD-L1 | CTLA4

China
Beijing Friendship Hospital

Recruiting

A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid Carcinoma

Papillary Thyroid Carcinoma | Thermal Ablation

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer

Recurrence | Thyroid Cancer

China
Peking Union Medical College Hospital

Recruiting

Cross-sectional Case and Control Study on Quality of Life, Appearance and Functions in PTC Via Different Surgical Approach

Papillary Thyroid Carcinoma | Thyroid Cancer

China
Geneplus-Beijing Co. Ltd.
Shanghai Chest Hospital

Recruiting

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

Lung Neoplasms | Adenocarcinoma of Lung | Lung Cancer, Nonsmall Cell | Squamous Cell Lung Cancer

China
Ze-yang Ding, MD
Geneplus-Beijing Co. Ltd.; Chinese Cooperative Group of Liver Cancer (CCGLC)

Recruiting

DEB-TACE, Lenvatinib and Anti-PD(L)1 Antibody as Conversion Therapy for Intrahepatic Cholangiocarcinoma (CCGLC-009)

Cholangiocarcinoma Non-resectable

China
Qilu Hospital of Shandong University
Shandong Provincial Hospital; Jinan Military General Hospital; Jinan Central...

Recruiting

Establishment of Scoring Model for Early and Differential Diagnosis of Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma

China
China Medical University, China

Recruiting

PD-1 Antibody + Apatinib Mesylate in 2+ Line Serum AFP-elevated Gastric Adenocarcinoma

Gastric Cancer | AFP

China
Tongji Hospital

Unknown

Comparing Three Dimension Laparoscopic Versus Open Surgery for Perihiliar Cholangiocarcinoma

Surgery | Cholangiocarcinoma, Perihilar

China
Tongji Hospital
Geneplus-Beijing Co. Ltd.; Chinese Cooperative Group of Liver Cancer (CCGLC)

Recruiting

Combined DEB-TACE, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma (CCGLC-012)

Cholangiocarcinoma Non-resectable

China
Hua Li

Recruiting

Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrahepatic Cholangiocarcinoma

Unresectable Intrahepatic Cholangiocarcinoma

China
Renmin Hospital of Wuhan University

Recruiting

Short-course Radiotherapy Combined With Neoadjuvant Chemotherapy and PD-1 Inhibitor in the Treatment of Locally Advanced Gastric Adenocarcinoma

Disorder in Complete Remission in Response to Treatment

China
Qingdao Central Hospital

Recruiting

Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic Carcinoma

Carcinoma, Adenoid Cystic

China
Jinan Military General Hospital

Completed

Comparison Between the Axillary Bilateral-breast Approach (ABBA) and Bilateral Axillo-breast Approach (BABA) for Robotic Thyroidectomy

Thyroidectomy | Thyroid Papillary Carcinoma

China
Fujian Medical University

Unknown

Prospective Study on the Clinical Prognosis of Bilateral Central Lymph Node Dissection in the Patients With Unilateral Thyroid Papillary Carcinoma

Thyroid Papillary Carcinoma

China
Fujian Medical University

Recruiting

A Study on the Safety and Efficacy of the Combination of Candenizumab, Lenvatinib, and SOX Regimen in the Treatment of HER2 Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Patients

Overall Response Rate

China
Ze-yang Ding, MD
Geneplus-Beijing Co. Ltd.; Chinese Cooperative Group of Liver Cancer (CCGLC)

Recruiting

Combined HAIC, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma (CCGLC-013)

Cholangiocarcinoma Non-resectable

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Study on Consistency Evaluation for Drug Sensitivity of Patient-Derived Organoid Model From Cholangiocarcinoma Patients

Cholangiocarcinoma

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Fruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Metastatic Gastric Cancer

China
First People's Hospital of Hangzhou

Enrolling by invitation

Spyglass+RFA Versus Cytobrush+RFA for Extrahepatic Cholangiocarcinoma

Malignant Biliary Obstruction | Extrahepatic Cholangiocarcinoma

China
Bo Wang,MD

Unknown

Study on the Application of Convenient Foot-control Exhaust Method in Endoscopic Thyroidectomy

Endoscopy | Papillary Thyroid Carcinoma | Thyroid Cancer | Thyroidectomy

China
Second Affiliated Hospital of Xi'an Jiaotong University

Recruiting

Prediction of Lymph Node Metastasis in Patients With Thyroid Malignancy by a New Scale

Papillary Thyroid Cancer

China
Zhujiang Hospital

Recruiting

Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma

Papillary Thyroid Cancer

China
Ruijin Hospital

Active, not recruiting

Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer

Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma

China
Betta Pharmaceuticals Co., Ltd.

Completed

Icotinib as an Adjuvant Therapy for Patients With Stage IIA-IIIA Adenocarcinoma With EGFR Mutation (ICAPE)

Non-small Cell Lung Cancer

China
Fudan University

Not yet recruiting

Perioperative Surufatinib Plus Sintilimab Combined With Chemotherapy in Gastric/Gastroesophageal Junction Adenocarcinoma

Gastric Cancer | Gastro Esophageal Junction Cancer

China
Shanghai Zhongshan Hospital

Active, not recruiting

Combined Therapy Using Oxaliplatin and Gemcitabine Chemotherapy, Lenvatinib and PD1 Antibody (JS001) for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma

Cholangiocarcinoma, Intrahepatic

China
First Affiliated Hospital Xi'an Jiaotong University
Shaanxi Provincial People's Hospital; Ningxia Medical University; Nanchang University and other collaborators

Completed

Routine Lymphadenectomy for Intrahepatic Cholangiocarcinoma (LND for ICC)

Intrahepatic Cholangiocarcinoma

China
First Affiliated Hospital, Sun Yat-Sen University
Guangdong Province, Department of Science and Technology

Unknown

VEGF Signaling Promotes Cell Growth and Metastasis in Extrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway (ECC) (VEGF ECC)

Extrahepatic Cholangiocarcinoma

China
First Affiliated Hospital, Sun Yat-Sen University
Guangdong Province, Department of Science and Technology

Unknown

VEGF Signaling Promotes Cell Growth and Metastasis in Intrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway (icc)

Intrahepatic Cholangiocarcinoma

China
Women's Hospital School Of Medicine Zhejiang University

Not yet recruiting

Effect of Compound Kushen Injection Combined With Pabolizumab in the Treatment of Cervical Adenocarcinoma

Cervical Cancer

China
Shi Ming

Suspended

Lenvatinib Plus PD-1 Antibody for Unresectable ICC

Intrahepatic Cholangiocarcinoma

China
AnHeart Therapeutics Inc.

Recruiting

IDH1 Inhibitor AB-218 in Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid Tumor

Cholangiocarcinoma With IDH1 Mutation | Solid Tumors With IDH1 Mutation

China
Changhai Hospital
Xijing Hospital; First People's Hospital of Hangzhou; LanZhou University; Peking... and other collaborators

Withdrawn

Application of Endoscopic Scissors Cutting ENBD Tube in the Treatment of Malignant Hilar Biliary Strictures (ENBD)

Endoscopic Retrograde Cholangiopancreatography | Klatskin Tumor

China
Fudan University

Unknown

Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma

Malignant Neoplasm Other Gallbladder/Extrahepatic Bile Duct

China
Eli Lilly and Company

Completed

Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric Adenocarcinomas

Adenocarcinoma

Japan
Shanghai Ninth People's Hospital Affiliated to...

Unknown

A Study of Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck

Adenoid Cystic Carcinoma

China
Shanghai 10th People's Hospital

Completed

The Risk Stratification of Papillary Thyroid Cancer With AUS/FLUS by FNA

Thyroid Cancer | Atypia of Undetermined Significance | FLUS

China
Qilu Pharmaceutical Co., Ltd.
Cend Therapeutics Inc.

Recruiting

CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma

Pancreatic Cancer

China
University of Texas Southwestern Medical Center

Withdrawn

Trial of Carbon Ion Versus Photon Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer (CIPHER)

Locally Advanced Pancreatic Adenocarcinoma

United States, Japan

3

Subscribe